In vitro antibacterial activities of a novel oxazolidinone, OCID0050 | Zendy

Maneesh PaulSatyaseela | Zendy; Shailendra Singh Solanki | Zendy; D. Sathishkumar | Zendy; Thirunavukkarasu Bharani | Zendy; V. Magesh | Zendy; Sridharan Rajagopal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro antibacterial activities of a novel oxazolidinone, OCID0050

Author(s) -

Maneesh PaulSatyaseela,

Shailendra Singh Solanki,

D. Sathishkumar,

Thirunavukkarasu Bharani,

V. Magesh,

Sridharan Rajagopal

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp300

Subject(s) - linezolid , minimum inhibitory concentration , potency , microbiology and biotechnology , vancomycin , in vitro , staphylococcus aureus , chemistry , antibacterial agent , antibiotics , pharmacology , medicine , biology , bacteria , biochemistry , genetics

In the pursuit of developing a second-generation oxazolidinone, we have identified OCID0050 as a novel oxazolidinone with enhanced activity against bacterial strains resistant to methicillin, vancomycin and linezolid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research